These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25599809)

  • 1. Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease.
    Norman P
    Expert Opin Investig Drugs; 2015 Mar; 24(3):383-92. PubMed ID: 25599809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the potential for inhaled p38 inhibitors in the treatment of chronic obstructive pulmonary disease?
    Millan DS
    Future Med Chem; 2011 Oct; 3(13):1635-45. PubMed ID: 21942253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial.
    Watz H; Barnacle H; Hartley BF; Chan R
    Lancet Respir Med; 2014 Jan; 2(1):63-72. PubMed ID: 24461903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p38 MAPK inhibitors: a patent review (2012 - 2013).
    Bühler S; Laufer SA
    Expert Opin Ther Pat; 2014 May; 24(5):535-54. PubMed ID: 24611721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases.
    Chopra P; Kanoje V; Semwal A; Ray A
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1411-25. PubMed ID: 18808304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p38alpha-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation.
    Medicherla S; Fitzgerald MF; Spicer D; Woodman P; Ma JY; Kapoun AM; Chakravarty S; Dugar S; Protter AA; Higgins LS
    J Pharmacol Exp Ther; 2008 Mar; 324(3):921-9. PubMed ID: 18056868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respivert's multikinase inhibitors, an evaluation of WO2014033446 to WO2014033449.
    Norman P
    Expert Opin Ther Pat; 2014 Dec; 24(12):1397-407. PubMed ID: 25407284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity.
    Hill RJ; Dabbagh K; Phippard D; Li C; Suttmann RT; Welch M; Papp E; Song KW; Chang KC; Leaffer D; Kim YN; Roberts RT; Zabka TS; Aud D; Dal Porto J; Manning AM; Peng SL; Goldstein DM; Wong BR
    J Pharmacol Exp Ther; 2008 Dec; 327(3):610-9. PubMed ID: 18776065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial.
    Fisk M; Cheriyan J; Mohan D; Forman J; Mäki-Petäjä KM; McEniery CM; Fuld J; Rudd JHF; Hopkinson NS; Lomas DA; Cockcroft JR; Tal-Singer R; Polkey MI; Wilkinson IB
    PLoS One; 2018; 13(3):e0194197. PubMed ID: 29566026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies.
    Pelaia C; Vatrella A; Gallelli L; Lombardo N; Sciacqua A; Savino R; Pelaia G
    Drug Des Devel Ther; 2021; 15():1275-1284. PubMed ID: 33790539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinase inhibitors and airway inflammation.
    Adcock IM; Chung KF; Caramori G; Ito K
    Eur J Pharmacol; 2006 Mar; 533(1-3):118-32. PubMed ID: 16469308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease.
    Barnes PJ
    Pharmacol Rev; 2016 Jul; 68(3):788-815. PubMed ID: 27363440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effect and selectivity profile of AS1940477, a novel and potent p38 mitogen-activated protein kinase inhibitor.
    Terajima M; Inoue T; Magari K; Yamazaki H; Higashi Y; Mizuhara H
    Eur J Pharmacol; 2013 Jan; 698(1-3):455-62. PubMed ID: 23183108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel strategies for inhibition of the p38 MAPK pathway.
    Zhang J; Shen B; Lin A
    Trends Pharmacol Sci; 2007 Jun; 28(6):286-95. PubMed ID: 17482683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and gastrointestinal tolerability of ML3403, a selective inhibitor of p38 MAP kinase and CBS-3595, a dual inhibitor of p38 MAP kinase and phosphodiesterase 4 in CFA-induced arthritis in rats.
    Koch DA; Silva RB; de Souza AH; Leite CE; Nicoletti NF; Campos MM; Laufer S; Morrone FB
    Rheumatology (Oxford); 2014 Mar; 53(3):425-32. PubMed ID: 24241037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives.
    Pelaia C; Vatrella A; Sciacqua A; Terracciano R; Pelaia G
    Expert Rev Respir Med; 2020 May; 14(5):485-491. PubMed ID: 32077346
    [No Abstract]   [Full Text] [Related]  

  • 17. RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-α and -γ selectivity, suppresses COPD inflammation.
    Charron CE; Russell P; Ito K; Lea S; Kizawa Y; Brindley C; Singh D
    Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29074542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Molecular Targets for New Drug Development for Chronic Obstructive Pulmonary Disease: What Does the Future Hold?
    Barnes PJ
    Semin Respir Crit Care Med; 2015 Aug; 36(4):508-22. PubMed ID: 26238638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New therapies for chronic obstructive pulmonary disease.
    Barnes PJ
    Med Princ Pract; 2010; 19(5):330-8. PubMed ID: 20639653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.
    Hope HR; Anderson GD; Burnette BL; Compton RP; Devraj RV; Hirsch JL; Keith RH; Li X; Mbalaviele G; Messing DM; Saabye MJ; Schindler JF; Selness SR; Stillwell LI; Webb EG; Zhang J; Monahan JB
    J Pharmacol Exp Ther; 2009 Dec; 331(3):882-95. PubMed ID: 19720877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.